Verition Fund Management’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.64M Buy
26,514
+7,889
+42% +$1.08M 0.02% 1065
2025
Q1
$3.36M Sell
18,625
-6,277
-25% -$1.13M 0.02% 954
2024
Q4
$3.9M Buy
24,902
+8,902
+56% +$1.39M 0.02% 835
2024
Q3
$2.91M Sell
16,000
-1,989
-11% -$362K 0.01% 847
2024
Q2
$3.3M Sell
17,989
-43,811
-71% -$8.05M 0.02% 679
2024
Q1
$11M Sell
61,800
-34,158
-36% -$6.08M 0.08% 253
2023
Q4
$11.9M Sell
95,958
-31,112
-24% -$3.86M 0.09% 175
2023
Q3
$14.7M Buy
127,070
+35,338
+39% +$4.1M 0.17% 126
2023
Q2
$10.8M Sell
91,732
-1,912
-2% -$224K 0.14% 156
2023
Q1
$7.5M Buy
93,644
+13,083
+16% +$1.05M 0.1% 228
2022
Q4
$6.38M Buy
80,561
+12,909
+19% +$1.02M 0.1% 216
2022
Q3
$4.72M Buy
67,652
+12,908
+24% +$900K 0.05% 373
2022
Q2
$3.59M Buy
54,744
+23,578
+76% +$1.55M 0.07% 368
2022
Q1
$2.07M Sell
31,166
-44,948
-59% -$2.99M 0.02% 637
2021
Q4
$5.32M Buy
76,114
+10,069
+15% +$704K 0.04% 246
2021
Q3
$3.45M Buy
66,045
+47,464
+255% +$2.48M 0.03% 275
2021
Q2
$1.26M Sell
18,581
-51,266
-73% -$3.49M 0.01% 599
2021
Q1
$5.38M Sell
69,847
-7,697
-10% -$593K 0.06% 132
2020
Q4
$4.65M Buy
77,544
+21,515
+38% +$1.29M 0.04% 149
2020
Q3
$2.41M Sell
56,029
-10,457
-16% -$450K 0.05% 170
2020
Q2
$2.75M Sell
66,486
-19,504
-23% -$808K 0.09% 137
2020
Q1
$3.72M Buy
85,990
+61,798
+255% +$2.67M 0.15% 64
2019
Q4
$1.34M Sell
24,192
-45,002
-65% -$2.49M 0.02% 287
2019
Q3
$2.4M Buy
69,194
+6,544
+10% +$227K 0.07% 153
2019
Q2
$2.52M Buy
+62,650
New +$2.52M 0.07% 152